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A rapid-onset type of behavioral sensitization (ROBS) has been demonstrated in rats treated with a single ‘priming’ injection of
amphetamine (AMP). In that species, however, this phenomenon was restricted to AMP-induced stereotyped behavior (SB), not
occurring for the locomotor-stimulant effect (LSE) of AMP and not reflecting environment-specific sensitization. In the present study, the
ROBS was characterized in the mouse. Mice received a single ‘priming’ intraperitoneal injection of 5.0 mg/kg AMP which was paired
or not with environment. At different intervals (3, 4 or 5 h) subgroups were tested for AMP (1.5 or 5.0 mg/kg)-induced SB or AMP
(1.5 mg/kg)-induced open-field LSE. Results showed that: (1) in the absence of drug–environment association, a priming injection
of AMP increased the SB induced by a 1.5 mg/kg AMP challenge injection given 3 h (but not 4 or 5 h) later; (2) when the dose of AMP
challenge injection was increased to 5.0 mg/kg, an enhancement of SB was verified at all the intervals tested (3, 4, and 5 h); (3) when
animals were tested in an open field, the priming injection of AMP produced an increase in the LSE of a 1.5 mg/kg AMP challenge
injection, given 4 h later; (4) drug–environment association increased both SB and locomotion after a saline challenge injection and
potentiated the rapid-onset sensitization of both behaviors in AMP-challenged mice. Collectively, these results demonstrate that the
ROBS phenomenon also occurs in mice, is extended to AMP-induced LSE, and is markedly potentiated by (but does not depend on)
environmental conditioning.
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While there is tolerance to many of the effects of repeated
drug treatments, the psychomotor and positive reinforcing
effects of amphetamine (AMP) and other drugs of abuse
often become progressively greater with repeated adminis-
tration (Robinson and Becker, 1986; Piazza et al, 1990;
De Vries et al, 1998). This phenomenon, called behavioral
sensitization, is usually measured in terms of locomotion or
stereotypy in rodents (Robinson and Becker, 1986; Wise
et al, 1996; Camarini et al, 2000). Sensitization of AMP-
induced stereotyped behavior (SB) is considered to be an
important model of dopaminergic nigrostriatal plasticity
(Robinson and Becker, 1986). As regards sensitization of the
locomotor-stimulatory effect of AMP (and other drugs of
abuse), this model has been suggested to be useful for
studying mechanisms underlying both dopaminergic meso-
accumbens plasticity (Henry and White, 1991; Wolf et al,
1994) and drug craving in humans (Robinson and Berridge,
1993).
The extent to which behavioral sensitization is induced by
drug pre-exposure is highly dependent on the environmental
context in which the injections are given as well as on the
nature of the pretreatment regimen. Concerning the envir-
onmental context, it has been suggested that environmental
cues might be conditioned stimuli for drug-like conditioned
responses, potentiating the development of behavioral
sensitization (Hayashi et al, 1980; Pierce and Kalivas, 1997;
Costa et al, 2001; Frussa-Filho et al, 2004). Although
sensitization of the locomotor-activating effect of AMP and
other drugs of abuse has been also observed when drug
injections are not paired with the observation environment
(Bellot et al, 1996, 1997; Costa et al, 2001), this environmental
modulation of sensitization is especially interesting because
it is well known that environmental cues trigger craving and
drug-seeking behavior in humans (Childress et al, 1986;
Niaura et al, 1988; Carter and Tiffany, 1999).
With respect to the nature of the pretreatment regimen, it
has been demonstrated that it is not necessary to repeatedly
administer AMP for long periods of time to produce
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behavioral sensitization. Indeed, a single injection of AMP
has been reported to enhance both stereotypy (Browne and
Segal, 1977; Ellison and Morris, 1981) and locomotor
stimulation (Vanderschuren et al, 1999a) produced by a
subsequent injection of AMP given weeks later. Within this
context, a more important variable appears to be the
interval between AMP treatment (or AMP single injection)
and the challenge injection of the drug. Indeed, several
studies have found that the magnitude of AMP-induced
behavioral sensitization gradually increases with prolonged
withdrawal after AMP-repeated treatment (Kolta et al, 1985;
Paulson et al, 1991; Vanderschuren et al, 1999b) or after
AMP single exposure (Vanderschuren et al, 1999a).
The above-mentioned temporal profile of the behavioral
sensitization phenomenon was however questioned by
studies performed by Kuczenski and Segal (1999a, b). They
demonstrated that the behavioral response of rats to low,
nonstereotypy doses of AMP (0.5–1.5 mg/kg) at very short
intervals (3–5 h) after an acute, ‘priming’, injection with
4.0 mg/kg AMP resulted in the emergence of intense, focused
stereotypies in the absence of an altered caudate-putamen
extracellular dopamine response. Such a finding might be
especially important within the context of binge patterns of
stimulant abuse involving frequent administration of the
drug at short intervals. However, its clinical implications
appear to be considerable attenuated by the experimental
suggestion that this rapid-onset behavioral sensitization
phenomenon did not occur for the locomotor-stimulant
effect (LSE) of AMP and did not reflect environment-specific
sensitization (Kuczenski and Segal, 1999a).
The present study had three purposes. These were to
determine (1) if this rapid-onset sensitization of AMP-
induced SB would also be verified in mice, (2) whether or
not the phenomenon would be also demonstrated for the
LSE of the drug, and (3) whether or not it would be




Subjects. Male EPM-M1 mice weighing 30–40 g were used.
The animals arrived at the experimental laboratory at least
10 days before the beginning of the experiments. They were
housed in plastic cages (32 42 18 cm), 15 per cage, with
ad libitum access to food and water. Light/dark cycle (lights
on at 07:00 h, off at 19:00 h) and temperature (221C) were
kept constant. All experiments took place between 08:00 and
18:00 h. The animals were maintained and used in
accordance with the guidelines of the Committee on Care
and Use of Laboratory Animal Resources, National
Research Council, USA.
Test agents. AMP (Sigma) was used. The drug was freshly
diluted in saline (SAL) solution and was given intraper-
itoneally in volumes not greater than 10 ml/kg body weight.
SAL was used as control solution.
Stereotypy studies. The animals were observed for SB in
wire mesh cages (16 30 18 cm) free of water and food.
Stereotypy was quantified every 5 min for 150 min after
AMP administration according to the scoring system
proposed by Setler et al (1976), with some modifications
validated in our laboratory for mice. Briefly, scores varying
from 0 to 4 were attributed to an animal’s behavior by an
observer who was unaware of the drug treatment. The
grading system was as follows: 0, asleep or stationary; 1,
active; 2, active with predominantly stereotyped sniffing
and rearing; 3, stereotyped sniffing with bursts of licking
and/or gnawing and biting; 4, continual licking and/or
gnawing of cage grids. Animals were used only once.
Open-field studies. At 15 min after injection, the animals
were individually placed in the center of the open-field
arena for direct quantification of locomotion frequency
during 5 min. The open-field apparatus used in the present
study was a circular wooden box (40 cm in diameter and
50 cm high) with an open top and a floor divided into 19
squares. Hand-operated counters were used to score
locomotion frequency (number of floor units entered)
during the 5-min sessions. This period of time has been
demonstrated to be effective in detecting AMP-induced
behavioral sensitization in mice (Bellot et al, 1997; Costa
et al, 2001; Frussa-Filho et al, 2004). All the observations
were conducted blind. The animals were used only once.
Experimental Procedure
Experiment 1. Time–response curve to 5.0 mg/kg AMP
acute administration in mice. In all, 20 mice were habituated
in individual polypropylene cages (20 30 12.5 cm) (IC)
for 150 min. After this time, 10 animals received an intra-
peritoneal injection of SAL (NaCl 0.9%) and the other 10
mice received an intraperitoneal injection of 5.0 mg/kg AMP.
Immediately later, they were placed in stereotypy observation
cages for SB quantification.
Experiment 2. Validation of the phenomenon of rapid-
onset sensitization of AMP-induced SB in mice and
possible involvement of drug-environment association. In
total, 117 mice were allocated to two groups (57–60 animals
each). Animals of the first group were habituated for
150 min in stereotypy observation cages (OC) and mice of
the second group were habituated in IC. After this period,
animals received an intraperitoneal injection of NaCl 0.9%
(SAL) or 5.0 mg/kg AMP (a dose which is effective in
inducing intense and focused SB in this species, in our
laboratorial conditions). Immediately after the respective
injections, animals that had been habituated in IC
were placed in OC (PAIR) and animals that had
been habituated in OC were placed in IC (NPAIR). The
animals were maintained in the respective environments for
150 min. After this period, all animals were placed in their
home cages. Animals of the four resulting groups (SAL-
NPAIR, AMP-NPAIR, SAL-PAIR, AMP-PAIR) were sub-
divided into three groups and received a challenge injection
of 1.5 mg/kg AMP (an ineffective dose to promote intense
and focused SB in mice, in our laboratorial conditions) 3, 4
or 5 h after their respective ‘priming’ injections). Immedi-
ately afterwards, all animals were placed in stereotypy
observation cages and SB was quantified. All the animals
were observed simultaneously, varying the time of the
priming injection.
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Experiment 3. Rapid-onset sensitization of AMP-induced
SB in mice and possible involvement of drug–environ-
ment association: effect of a higher dose of AMP challenge
injection. In all, 120 mice were allocated to two groups (60
animals each). Half of the animals were habituated for
150 min in stereotypy observation cages (OC) and the other
half were habituated in IC as described in experiment 2.
Animals of the four resulting groups (SAL-NPAIR, AMP-
NPAIR, SAL-PAIR, AMP-PAIR) were subdivided into three
groups and received a challenge injection of 5.0 mg/kg AMP
3, 4, or 5 h after their respective priming injections.
Immediately later, all animals were placed in stereotypy
observation cages and SB was quantified. All the animals
were observed simultaneously, varying the time of the
priming injection.
Experiment 4. Rapid-onset sensitization of AMP-induced
SB in mice and possible involvement of drug–environ-
ment association: effect of a SAL challenge injection.
(a) A total of 39 mice were allocated to two groups of 19–20
animals each. Animals were habituated and received
injections as described in experiment 2. At 3 h after their
respective priming injections, animals of each group
(SAL-NPAIR, AMP-NPAIR, SAL-PAIR, and AMP-PAIR)
received a SAL challenge injection and were, immedi-
ately later, placed in the stereotypy observation cages,
for quantification of this behavior.
(b) A total of 40 mice were allocated to two groups of 20
animals each. Animals were habituated and received
injections as described in experiment 2. At 4 h after their
respective priming injections, animals of each group
(SAL-NPAIR, AMP-NPAIR, SAL-PAIR, and AMP-PAIR)
received a SAL challenge injection and were, immedi-
ately later, placed in the stereotypy observation cages,
for quantification of this behavior.
Experiment 5. Demonstration of the LSE of 5.0 mg/kg in
the open-field behavior of mice. In all, 14 mice received
SAL injection (n¼ 6) or 5.0 mg/kg AMP (n¼ 8). After
15 min, locomotor activity in the open field (OF) was
quantified.
Experiment 6. Demonstration of the phenomenon
of rapid-onset sensitization of AMP-induced locomotor
activation in mice and the involvement of drug–environ-
ment association. A total of 40 mice were allocated to
two groups (20 animals each). Half of the animals
were habituated for 150 min in an OF and the other
half were habituated in IC. After this period, they received
an intraperitoneal injection of NaCl 0.9% (SAL) or
5.0 mg/kg AMP. Immediately after the respective priming
injections, animals that had been habituated in the IC
were placed in the OF (PAIR) and animals that had been
habituated in the OF were placed in the IC (NPAIR).
The animals were maintained in the respective environ-
ments for 150 min. After this period, all animals were placed
in their home cages. At 4 h after their respective priming
injections, animals of the four resulting groups (SAL-
NPAIR, AMP-NPAIR, SAL-PAIR, and AMP-PAIR) received
a challenge injection of 1.5 mg/kg AMP. After 15 min, all the
animals were placed in the OF and locomotor activity was
measured.
Experiment 7. Rapid-onset sensitization of AMP-induced
locomotor stimulation in mice and possible involvement
of drug–environment association: effect of a SAL chal-
lenge injection. In all, 39 mice were allocated to two groups
of 19–20 animals each. Animals were habituated and
received injections as described in experiment 6. At 4 h
after their respective priming injections, animals of each
group (SAL-NPAIR, AMP-NPAIR, SAL-PAIR, and AMP-
PAIR) received a SAL challenge injection and, 15 min later,
were placed in an OF for locomotor activity quantification.
RESULTS
Experiment 1. Time–Response Curve to 5.0 mg/kg AMP
Acute Administration in Mice
Figure 1 shows the time–response curve to the SB of
mice acutely treated with 5.0 mg/kg AMP. As compared
to SAL-treated mice, the scores of SB presented by
AMP-treated mice were significantly higher (Student’s
t-test) until 135 min after injection. Thus, by 150 min after
Figure 1 Experiment 1. Time–response curve to 5.0 mg/kg AMP acute administration in mice. In all, 20 mice were habituated in IC for 150 min. After this
time, 10 animals received an intraperitoneal injection of SAL (NaCl 0.9%) and the other 10 mice received an intraperitoneal injection of 5.0 mg/kg AMP.
Immediately later, they were placed in stereotypy observation cages for SB quantification. *po0.05 compared to the control group (SAL). Student’s t-test.
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5.0 mg/kg AMP treatment, SB had completely ceased.
Table 1 shows the total values of the SB during the
150-min observation. The Student’s t-test revealed a
significant difference between SAL and AMP (T(18)¼ 7.80;
po0.001).
Experiment 2. Validation of the Phenomenon of Rapid-
Onset Sensitization of AMP-Induced SB in Mice and
Possible Involvement of Drug–Environment Association.
Figure 2 shows the SB induced by 1.5 mg/kg AMP in animals
pretreated with a priming injection of SAL or 5.0 mg/kg
AMP (associated or not with the observation cage), given 3,
4, or 5 h before. A three-way ANOVA revealed significant
effects for pretreatment (SAL or AMP) (F(1,105)¼ 50.71;
po0.001), pairment (NPAIR or PAIR) (F(1,105)¼ 24.72;
po0.001), and time (3, 4, or 5 h after injection)
(F(2,105)¼ 4.72; po0.001), and also for interaction between
pretreatment and pairment (F(1,105)¼ 16.15; po0.001) and
between pretreatment and time (F(2,105)¼ 5.60; po0.01).
At 3 h after the priming injection, animals of both the AMP-
NPAIR group (in which the priming 5.0 mg/kg AMP
injection was not paired to the stereotypy observation
cages) and AMP-PAIR group (in which the 5.0 mg/kg
AMP priming injection was paired to the stereotypy
observation cages) showed significantly higher SB than that
presented by animals of their respective control (SAL-
pretreated) groups (F(11,105)¼ 12.89; po0.001). At 4 and
5 h after the priming injection, only animals of the AMP-
PAIR group presented a significantly higher stereotypy than
that presented by their respective control (SAL) groups as
well as significantly higher than that presented by animals
of the respective AMP-NPAIR group, including the 3-h
interval.
Experiment 3. Rapid-Onset Sensitization of
AMP-Induced SB in Mice: Effect of a Higher
Dose of AMP Challenge Injection
Figure 3 shows SB induced by 5.0 mg/kg AMP in animals
pretreated with a priming injection of SAL or 5.0 mg/kg
AMP given 3, 4, or 5 h before. A three-way ANOVA revealed
significant effects for pretreatment (SAL or AMP)
(F(1,108)¼ 124.67; po0.001), pairment (NPAIR or PAIR)
(F(1,108)¼ 10.49; po0.001), and time (3, 4, or 5 h after
injection) (F(2,108)¼ 6.28; po0.001), as well as for inter-
action between pretreatment and pairment (F(1,108)¼ 6.39;
po0.001). At 3, 4, or 5 h after the priming injection, animals
of the AMP-NPAIR and AMP-PAIR groups presented
significantly higher SB than that presented by their
respective control (SAL) groups (F(11,108)¼ 14.21;
po0.001). At 4 and 5 h after the priming injection, animals
of the AMP-PAIR group also presented a significant
increase in SB when compared to animals of the AMP-
NPAIR group.
Table 1 Total Score of Stereotyped Behavior during 150 min after
Saline or 5.0 mg/kg Amphetamine i.p. Acute Administration
Injection Total stereotypy score
Saline 15.8072.66
Amphetamine 38.8071.28*
*po0.05 compared to saline-treated mice. Student’s t-test.
Figure 2 Experiment 2. Validation of the phenomenon of rapid-onset sensitization of AMP-induced SB in mice and possible involvement of drug–
environment association. Animals (n¼ 8–10) received a SAL or 5.0 mg/kg AMP priming injection and were paired (PAIR) or not (NPAIR) to the stereotypy
observation cages as described in experimental procedure. At 3, 4, or 5 h after their respective priming injections, all the animals received 1.5 mg/kg AMP
and, immediately later, were placed in stereotypy observation cages for SB quantification. *po0.001 compared to the SAL group with the same conditions
of pairment and interval between injections.J, po0.001 compared to the N-PAIR group with the same conditions of pretreatment and interval between
injections. ANOVA followed by Duncan test.
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Experiment 4. Rapid-Onset Sensitization of
AMP-Induced SB in Mice and Possible
Involvement of Drug–Environment Association:
Effect of a SAL Challenge Injection
Figures 4 and 5 show the effects of a SAL challenge injection
3 or 4 h after the priming injection of SAL or 5.0 mg/kg
AMP, respectively. Concerning the 3-h interval, a two-way
ANOVA revealed a significant effect of pretreatment only
(SAL or AMP) (F(1,35)¼ 16.01; po0.001). Indeed, animals
of both groups that had received a previous injection of
AMP (AMP-NPAIR and AMP-PAIR groups) presented a
significantly higher SB than that presented by the respective
animals of control (SAL) groups. At 4 h after the priming
injections, a two-way ANOVA revealed a significant effect of
pretreatment (SAL or AMP) (F(1,36)¼ 11.23; po0.05). The
interaction between pretreatment and pairment conditions
just missed significance (F(1,36)¼ 4.04; p¼ 0.052). Indeed,
Figure 3 Experiment 3. Rapid-onset sensitization of AMP-induced SB in mice and possible involvement of drug–environment association: effect of a
higher dose of AMP challenge injection. Animals (n¼ 10) received a SAL or 5.0 mg/kg AMP priming injection and were paired (PAIR) or not (NPAIR) to the
stereotypy observation cages as described in experimental procedure. At 3, 4, or 5 h after their respective priming injections, all the animals received 5.0 mg/
kg AMP and, immediately later, were placed in stereotypy observation cages for SB quantification. *po0.001 compared to the SAL group with the same
conditions of pairment and interval between injections.J, po0.001 compared to the N-PAIR group with the same conditions of pretreatment and interval
between injections. ANOVA test followed by Duncan test.
Figure 4 Experiment 4A. Rapid-onset sensitization of AMP-induced SB
in mice and possible involvement of drug–environment association: effect
of a SAL challenge injection. Animals (n¼ 9–10) received a SAL or 5.0 mg/
kg AMP priming injection which was paired (PAIR) or not (NPAIR) to the
stereotypy observation cages. At 3 h after their respective priming
injections, all the animals received a SAL challenge injection and,
immediately later, were placed in the stereotypy observation cages for
SB quantification. *po0.05 compared to the respective SAL group.
ANOVA followed by Duncan test.
Figure 5 Experiment 4B. Rapid-onset sensitization of AMP-induced SB
in mice and possible involvement of drug–environment association: effect
of a SAL challenge injection. Animals (n¼ 9–10) received a SAL or 5.0 mg/
kg AMP priming injection which was paired (PAIR) or not (NPAIR) to the
stereotypy observation cages. At 4 h after their respective priming
injections, all the animals received a SAL challenge injection and,
immediately later, were placed in the stereotypy observation cages for
SB quantification. *po0.05 compared to the respective SAL group.
ANOVA followed by Duncan test.
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only the animals of the AMP-PAIR group (and not those of
the AMP-NPAIR group) presented a significant increase in
stereotypy when compared to the respective control (SAL)
pretreated group.
Experiment 5. Demonstration of the LSE of 5.0 mg/kg
in the Open-Field Behavior of Mice
Student’s t-test showed that mice acutely treated with an
intraperitoneal injection of 5.0 mg/kg AMP presented a
significantly higher locomotion frequency (556.5723.5F
mean7SE) than that presented by animals acutely treated
with SAL (116.279.3) (T(12)¼ 15.40; po0.001).
Experiment 6. Demonstration of the Phenomenon of
Rapid-Onset Sensitization of AMP-Induced Locomotor
Activation in Mice and the Involvement of
Drug–Environment Association
A two-way ANOVA revealed significant effects of pretreat-
ment (SAL or AMP) (F(1,36)¼ 78.00; po0.001), pairment
(NPAIR and PAIR) (F(1,36)¼ 26.15; po0.001), and inter-
action between both factors (F(1,36)¼ 30.16; po0.001).
Figure 6 shows that animals of the AMP-PAIR group
presented a significantly higher locomotion frequency than
that presented by all the other groups (F(3,36)¼ 44.77;
po0.001). In addition, animals of the AMP-NPAIR group
presented locomotion frequency higher than that presented
by animals of the respective control group SAL-NPAIR
(Figure 6).
Experiment 7. Rapid-Onset Sensitization of
AMP-Induced Locomotor Stimulation in Mice
and Possible Involvement of Drug–Environment
Association: Effect of a SAL Challenge Injection
In experiment 7, two-way ANOVA revealed significant
effects of pretreatment (SAL or AMP) (F(1,35)¼ 24.26;
po0.001), pairment (NPAIR or PAIR) (F(1,35)¼ 34.93;
po0.001), and interaction between both factors (F(1,35)¼
9.23; po0.001). Figure 7 shows that animals of the AMP-
PAIR group presented a significant increase in locomotion
frequency when compared to all the other groups
(F(3,35)¼ 21.75; po0.001).
DISCUSSION
The major findings of the present study were that: (1) as
previously demonstrated in the rat (Kuczenski and Segal,
1999a, b), a priming injection of a high dose of AMP
induced a very rapid (3–5 h)-onset sensitization to the SB
induced by a subsequent injection of both a low or a high
dose of the drug, in the mouse; (2) opposite to previously
described in the rat (Kuczenski and Segal, 1999a), a rapid-
onset sensitization to the locomotor-stimulating effect of
AMP was also demonstrated in the mouse, and (3) this
rapid-onset behavioral sensitization to AMP in mice did not
require environmental conditioning to develop, but a
conditioned association between the drug effect and
the environment in which the behavior was quantified
markedly increased the magnitude of the sensitization
phenomenon.
The first series of experiments presented in our study
Frelated to AMP-induced SB in the mouseFmarkedly
replicates the stereotypy data of Kuczenski and Segal
(1999a), in rats. Indeed, in the latter study, it was
demonstrated that after a priming AMP dose of 4.0 mg/kg
and a low-dose challenge of 0.5 mg/kg, significant sensitiza-
tion to SB was verified only when the challenge injection
was administered 3 h (but not 4 or 5 h) after the priming
injection. However, when rats were challenged with a higher
dose (1.5 mg/kg) of AMP, sensitization to SB was significant
at all tested intervals (3, 4, and 5 h). In the present study,
after a priming AMP dose of 5.0 mg/kg and a low-dose (for
Figure 6 Experiment 6. Demonstration of the phenomenon of rapid-
onset sensitization of AMP-induced locomotor activation in mice and the
involvement of drug–environment association. Animals (n¼ 10) received a
SAL or 5.0 mg/kg AMP priming injection which was paired (PAIR) or not
(NPAIR) to the open-field apparatus. At 4 h after their respective priming
injections, all the animals received 1.5 mg/kg AMP challenge injection and
15 min later their open-field locomotor activity was quantified. *po0.001
compared to the other groups. J, po0.001 compared to the respective
SAL group (SAL-NPAIR). ANOVA followed by Duncan test.
Figure 7 Experiment 7. Rapid-onset sensitization of AMP-induced
locomotor stimulation in mice and possible involvement of drug–
environment association: effect of a SAL challenge injection. Animals
(n¼ 9–10) received a SAL or 5.0 mg/kg AMP priming injection which was
paired (PAIR) or not (NPAIR) to the open-field apparatus. At 4 h after their
respective priming injections, all the animals received a SAL challenge
injection and 15 min later their open-field locomotor activity was quantified.
*po0.001 compared to all other groups. ANOVA followed by Duncan
test.
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mice) challenge of 1.5 mg/kg, significant sensitization to
stereotypy was also verified at 3 h (but not 4 or 5 h)
intervals. Notwithstanding, sensitization was significant at
all intervals tested when the challenge dose of AMP was
increased (5.0 mg/kg). Taken together, the present data and
those reported by Kuczenski and Segal (1999a) suggest
that this rapid-onset sensitization to AMP-induced SB is
a quite consistent and reproducible phenomenon, even in a
different species.
Although confirming the notion that this rapid-onset
sensitization to AMP-induced SB can develop in the absence
of environmental conditioning (Kuczenski and Segal,
1999a), our data clearly show that such a conditioning can
strongly potentiate this kind of sensitization. Indeed, when
the behavioral effect (stereotypy) induced by AMP priming
injection had been paired to the observation cage, the
intensity of SB induced by a challenge (both 1.5 and 5.0
mg/kg) injection of the drug was always (at all intervals)
significantly enhanced as compared to control animals
equally paired to environment but ‘primed’ with SAL. In
addition, with the exception of the 3-h interval in
experiment 2 (challenge with 5.0 mg/kg), the SB of these
mice was also always significantly higher than that
presented by animals that had been equally ‘primed’ with
AMP but had not been paired to the observation cage.
Furthermore, when animals that had received a priming
injection of AMP paired to the observation cage were
challenged with SAL 4 h later, they presented a significant
increase in spontaneous SB as compared to all the other
groups.
Interestingly, at the 3 h interval, mice that received a
priming injection of AMP presented a significant increase in
spontaneous stereotypy (SAL challenge) irrespective of the
pairment condition. At first, one could argue that this effect
could be due to residual levels of AMP or increased
extracellular dopamine. However, this appears not to be the
case since we demonstrated that 140 min after the priming
injection of AMP (5.0 mg/kg) SB had completely ceased (see
Figure 1). According to this analysis, Kuczenski and Segal
(1999a) demonstrated that the rapid-onset (three-hour
interval) sensitization to AMP in rats occurred without a
corresponding increase in extracellular dopamine levels. In
this respect, after AMP administration, extracellular dopa-
mine concentrations are highly correlated with extracellular
concentrations of AMP, and the rate constants for the
decline of extracellular dopamine, extracellular AMP, and
tissue levels of AMP are comparable (Kuczenski et al, 1997).
Thus, an alternative hypothesis to explain the spontaneous
stereotypy presented 3 h later by mice which had received a
priming dose of AMP in the absence of environmental
pairment might be the development of a Pavlovian
conditioning between AMP-induced SB and the injection
procedure. In this respect, priming intraperitoneal injection
of AMP was accompanied by a number of cues predictive of
drug administration, such as the appearance of the
experimenter, handling, and a needle prick. This injection
procedure conditioning to drug behavioral effects has been
clearly demonstrated previously (Chinen and Frussa-Filho,
1999). In line with the above-discussed possibility, while it
is well known that conditioned responses declined with
time, the spontaneous stereotypy presented by mice
previously treated with a nonenvironmental paired priming
injection of AMP was no longer present when the interval
between the priming injection of AMP and the challenge
injection of SAL was increased to 4 h.
The demonstration that drug–environmental condition-
ing, although not necessary for, can powerfully potentiate
the development of the rapid-onset sensitization to AMP-
induced SB is completely in line with the current notion of
the influence of such a conditioning mechanism on the
classic (late onset and associated with repeated AMP
administration) behavioral sensitization phenomenon (see
Robinson and Becker (1986) and Introduction). Thus, both
the rapid- and the late-onset types of the behavioral
sensitization phenomenon appear to share some common
mechanisms and characteristics. In terms of this concep-
tualization, Kuribara (1994, 1996) demonstrated that
although the ambulation-increasing effect of methAMP
disappeared by 3 h after the administration of the drug, a
3-h post-treatment with different neuroleptic agents after
each metAMP administration was effective for a significant
inhibition of the induction of the sensitization induced by
repeated treatment with the psychostimulant. Thus, stimu-
lation of dopamine receptors during the early post-
treatment period following each drug administration may
be critical for the development of the behavioral sensitiza-
tion phenomenon.
One of the most important findings of the present
investigation was that the rapid-onset kind of the behavioral
sensitization phenomenon was not specific for AMP-
induced stereotypies, but was also demonstrated for AMP-
induced LSE in mice. This result differs from that of
Kuczenski and Segal (1999a) who found that the LSE of
AMP did not undergo to rapid-onset sensitization in rats.
Perhaps, more important than differences in experimental
subjects (ratsmice), differences in the methodological
quantification of stereotyped and locomotor behaviors may
account for these differences in results. Indeed, in the study
of Kuczenski and Segal (1999a, b), both kinds of behavior
were quantified in the same experimental rectangular
chambers. Possibly because of the lack of specificity of the
chamber to measure each behavior, there was a clear-cut
competition between locomotor and SB such that stereotypy
replaced locomotor activation. In the present study, the use
of a circular open-field apparatus (without corners) to
specifically measure locomotor behavior as well as the use
of rectangular wire mesh cages to measure SB allowed the
expression of the locomotor activating and the stereotyped
effects of AMP, at the same doses.
Most, if not all, drugs with abuse potential stimulate
locomotion in rodents. This locomotor stimulation has been
extensively related to increased dopaminergic neurotrans-
mission in the mesoaccumbens system (Kelly et al, 1975;
Pijnenburg et al, 1975; Delfs et al, 1990), which has been
extensively related to drug reward (Di Chiara and Imperato,
1988; Koob, 1992; Weiss et al, 1992; Self and Nestler, 1995).
Within this context, sensitization to the LSE of AMP and
other drugs of abuse has been hypothesized to reflect
neuronal adaptations which seem to be crucial to the
development of drug addiction (Wise and Bozarth, 1987;
Robinson and Berridge, 1993). The present study shows
thatFin contrast to the initial conclusions of Kuczenski
and Segal (1999a, b)Fthere is a clear-cut rapid-onset
sensitization to the AMP-induced locomotor-activating
Rapid-onset sensitization to amphetamine in mice
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effect, which is powerfully potentiated by environmental
conditioning. The basic as well as the clinical implications
of such a finding may be far reaching.
A final comment concerns the demonstration of environ-
mental cue-induced conditioned stereotyped and locomotor
responses after a single environment–drug effect pairment
(SAL challenge experiments). Independently of the ability to
potentiate the behavioral sensitization phenomenon, these
conditioned responses are per se considered animal models
to study addiction (Damianopoulos and Carey, 1992; Carey
and Damianopoulos, 1994; Hotsenpiller et al, 2002;
Hotsenpiller and Wolf, 2002a). Within this context, it has
been shown that conditioned locomotion is not directly
correlated to behavioral sensitization to psychostimulants
(Carey and Gui, 1998; Hotsenpiller et al, 2001; Hotsenpiller
and Wolf, 2002b). Thus, the demonstration of a very quick
and simple experimental design to specifically study such
an important conditioning phenomenon may be of
considerable methodological interest.
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